Cargando…
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
RATIONALE: Cannabidiol (CBD), the major non-psychoactive constituent of cannabis, has therapeutic potential for the treatment of anxiety. Most preclinical studies investigate only acute effects of CBD and only in males, yet the drug is most likely to be used over a sustained period in clinical pract...
Autores principales: | Fabris, Débora, Carvalho, Milene C, Brandão, Marcus L, Prado, Wiliam A, Zuardi, Antônio W, Crippa, José A, de Oliveira, Amanda R, Lovick, Thelma A, Genaro, Karina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716492/ https://www.ncbi.nlm.nih.gov/pubmed/36239039 http://dx.doi.org/10.1177/02698811221125440 |
Ejemplares similares
-
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
por: Genaro, Karina, et al.
Publicado: (2017) -
Myristic Acid Produces Anxiolytic-Like Effects in Wistar Rats in the Elevated Plus Maze
por: Contreras, Carlos M., et al.
Publicado: (2014) -
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
por: Zuardi, Antonio W., et al.
Publicado: (2017) -
The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disorder recall their trigger event
por: Bolsoni, Lívia Maria, et al.
Publicado: (2022) -
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
por: Breuer, Aviva, et al.
Publicado: (2016)